How to Future-Proof Your Company with Smarter IT Choices 
BOSS Zhipin Continues Share Repurchases: More than RMB340M in 2026 Under Buyback Program Good Supply Brand Expands Its Award-Winning Cannabis Portfolio with Hash Bats™; A New ‘Hard-Hitting’ Infused Pre-Roll
Good Supply Hash Bats Educational overview of a Hash Bat. TORONTO, March 08, 2022 (GLOBE…
Harvard Bioscience Announces Fourth Quarter 2021 Financial Results
Revenue up 7% year-over-year as sales momentum continues, despite global supply chain headwinds Gross margin…
Sigilon Therapeutics to Present at the Barclays Global Healthcare Conference
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology…
First Wave BioPharma to Participate in ”Fireside Chat” at the 34th Annual Roth Conference
Fireside Chat scheduled for Tuesday, March 15, 2022, at 9:30 a.m., PT BOCA RATON, Fla.,…
PolyPid to Deliver Poster Presentation at SAGES 2022
Presentation Evaluates Efficacy of D-PLEX100 in Reducing Surgical Site Infection Rates in Elective Colorectal Surgery…
Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray
The Extended Immunohematology microarray provides labs with comprehensive characterization, simplified workflow, and high throughput—all on…
MiroBio Continues Expansion of Executive Leadership Team with Key Appointments to Advance Development of Checkpoint Agonist Antibodies for Autoimmune Disease
Sanjay Keswani, MBBS, FRCP Sanjay Keswani, MBBS, FRCP Lynne Murray, Ph.D., MBA Lynne Murray, Ph.D.,…
Entera Bio Reports Financial Results for the Year Ended December 31, 2021
— EB613 expected to commence pivotal Phase 3 Osteoporosis trial in 2022 —— New EB612…
Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
– Fifteen Patients Enrolled to Date in Cohort 4 of EnACT (all oral induction regimen);…
Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
License option agreement with Novartis for target-specific access to TRACER™ next-generation AAV capsids for potential use…
Xüdle’s New Profitability Guide Helps Wineries Increase Sales in Current Economic Climate
New e-book provides wineries of all sizes with tips to improve bottom line revenue and…
RETRANSMISSION: HIVE Blockchain Provides Update on February 2022 Production and At-The-Market Offering and Conclusion of Canadian At-The-Market Offering
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
Orbs Expands to Fantom to Enhance L3 DeFi Capabilities
Orbs continues to push the boundaries of multi-chain interoperability as part of its Orbs 3.0…
Yuanxi Creative Design (Beijing) Co., Ltd. Aims to Integrate Buddhist Faith with Interior Design
Beijing, China–(Newsfile Corp. – March 8, 2022) – Chinese interior designer Duan Yuan, who is…
Global Aerospace and Defense Company Selects CoreSite to Support Its Modern Hybrid IT Strategy
Organization Requirements Include Secure, Reliable Colocation and Native Cloud Onramps in a State-of-the-Art Data Center…
CPI Card Group Inc. Reports Fourth Quarter and Full Year 2021 Results
Fourth Consecutive Year of Strong Sales Growth; Full Year Net Sales Increased 20% to $375.1…
DNA Script Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022
Company’s enzymatic DNA printing on demand technology recognized among top-ranked in the biotech category. SOUTH…
Heliogen Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022
Concentrated solar thermal energy company joins the ranks of past winners including Microsoft, SpaceX, Moderna,…
Veritone’s AI-powered iDERMS Solution Selected by Competitive Power Ventures for Energy Market Price Forecasting in PJM
The solution will provide day-ahead and real-time energy price forecasting to maximize the value and…
Rocket Pharmaceuticals Appoints Jessie Yeung as Vice President of Investor Relations and Corporate Finance
CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable…